Propylthiouracil-associated rapidly progressive crescentic glomerulonephritis with double positive anti-glomerular basement membrane and antineutrophil cytoplasmic antibody: the first case report

详细信息    查看全文

• 作者：Pitchaporn Kantachuvesiri ; Panas Chalermsanyakorn…
• 关键词：Anti ; glomerular basement membrane antibody ; Antineutrophil cytoplasmic antibody ; Crescentic glomerulonephritis ; Propylthiouracil
• 刊名：CEN Case Reports
• 出版年：2015
• 出版时间：November 2015
• 年：2015
• 卷：4
• 期：2
• 页码：180-184
• 全文大小：1,250 KB
• 参考文献：1.Wu R, Li R. Propylthiouracil-induced autoimmune syndromes: 11 case report. Rheumatol Int. 2012;32:679鈥?1.CrossRef PubMed
  2.Poomthavorn P, Mahachoklertwattana P, Tapaneya-Olarn W, et al. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves鈥?disease. J Med Assoc Thai. 2002;85(Suppl 4):S1295鈥?01.PubMed
  3.Kudoh Y, Kuroda S, Shimamoto K, et al. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. Clin Nephrol. 1997;48:41鈥?.PubMed
  4.Xu X, Zhao M, Zhang Y, et al. Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review. Zhonghua Nei Ke Za Zhi. 2002;41:404鈥?.PubMed
  5.Noh JY, Yasuda S, Sato S, et al. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab. 2009;94:2806鈥?1.CrossRef PubMed
  6.Cala帽as-Continente A, Espinosa M, Manzano-Garc铆a G, et al. Necrotizing glomerulonephritis and pulmonary hemorrhage associated with carbimazole therapy. Thyroid. 2005;15:286鈥?.CrossRef PubMed
  7.Jarraya F, Abid M, Jlidi R, et al. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with benzylthiouracil therapy: report of the first case. Nephrol Dial Transplant. 2003;18:2421鈥?.CrossRef PubMed
  8.Yu F, Chen M, Gao Y, et al. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis. 2007;49:607鈥?4.CrossRef PubMed
  9.Chen M, Gao Y, Guo XH, et al. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Nat Rev Nephrol. 2012;8:476鈥?3.CrossRef PubMed
  10.Merkel PA. Drug induced vasculitis. Rheum Dis Clin North Am. 2001;27:849鈥?2.CrossRef PubMed
  11.Wada N, Mukai M, Kohno M, et al. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves鈥?disease treated with propylthiouracil and thiamazole. Endocr J. 2002;49:329鈥?4.CrossRef PubMed
  12.Lau EY, Song SY, Chan E, et al. Methimazole-induced antineutrophil cytoplasmic antibody-associated diffuse alveolar haemorrhage in a Chinese woman with Graves鈥?disease. Hong Kong Med J. 2009;15:209鈥?2.PubMed
  13.Ahmed K, Rao S, Simha V. Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with graves disease: cross-reaction between propylthiouracil and methimazole. Endocr Pract. 2010;16:449鈥?1.CrossRef PubMed
  14.Slot MC, Links TP, Stegeman CA, et al. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with anti-thyroid drugs: a long-term follow-up study. Arthritis Rheum. 2005;53:108鈥?3.CrossRef PubMed
  15.Serratrice J, Chiche L, Dussol B, et al. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis. 2004;43:e26鈥?0.CrossRef PubMed
  16.Bosch X, Mirapeix E, Font J, et al. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol. 1991;36:107鈥?3.PubMed
  17.Bonsib SM, Goeken JA, Kemp JD, et al. Coexistent anti-neutrophil cytoplasmic antibody and antiglomerular basement membrane antibody associated disease = report of six cases. Mod Pathol. 1993;6:526鈥?0.PubMed
  18.Levy JB, Hammad T, Coulthart A, et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004;66:1535鈥?0.CrossRef PubMed
  19.Rutgers A, Slot M, van Paassen P, et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis. 2005;46:253鈥?2.CrossRef PubMed
  20.Kahsai TZ, Enders GC, Gunwar S, et al. Seminiferous tubule basement membrane. Composition and organization of type IV collagen chains, and the linkage of 伪3(IV) and 伪5(IV) chains. J Biol Chem. 1997;272:17023鈥?2.CrossRef PubMed
  21.Brainwood D, Kashtan C, Gubler MC, et al. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int. 1998;53:762鈥?.CrossRef PubMed
  22.Gunwar S, Ballester F, Kalluri R, et al. Glomerular basement membrane: identification of dimeric subunits of the noncollagenous domain (hexamer) of collagen IV and the Goodpasture antigen. J Biol Chem. 1991;266:15318鈥?4.PubMed
  23.Plaisier E, Borradori L, Hellmark T, et al. Anti-glomerular basement membrane nephritis and bullous pemphigoid caused by distinct anti-alpha 3(IV)NC1 and anti-BP180 antibodies in a patient with Crohn鈥檚 disease. Am J Kidney Dis. 2002;40:649鈥?4.CrossRef PubMed
  
• 作者单位：Pitchaporn Kantachuvesiri (1)
  Panas Chalermsanyakorn (2)
  Bunyong Phakdeekitcharoen (1)
  Thitima Lothuvachai (1)
  Kannika Niticharoenpong (1)
  Piyanuch Radinahamed (1)
  Neil Turner (3)
  Surasak Kantachuvesiri (1)
  
  1. Division of Nephrology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Rama VI Road, Phaya Thai, Bangkok, 10400, Thailand
  2. Department of Pathology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  3. Renal and Autoimmunity Group, MRC Centre for Inflammation, University of Edinburgh, Edinburgh, UK
  
• 刊物主题：Nephrology; Urology/Andrology;
• 出版者：Springer Japan
• ISSN：2192-4449

文摘

We report a case of propylthiouracil (PTU)-induced double antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody (anti-GBM antibody) disease causing pulmonary-renal syndrome in a 35-year-old Thai woman with 10-year history of PTU treatment for thyrotoxicosis. She developed clinical symptoms of vasculitis upon receiving long-term PTU treatment. Prednisolone treatment and the switching from PTU to methimazole resulted to short-term clinical improvement. Nevertheless following termination of steroid treatment, she developed recurrent pulmonary hemorrhage and rapidly progressive glomerulonephritis. The kidney biopsy showed crescentic glomerulonephritis with linear IgG deposit on the glomerular basement membrane although transbronchial lung biopsy showed no immune deposit along the alveolar basement membrane. Serum testing for p-ANCA was positive and western blot showed positive antibody to the alpha-3 chain of collagen type IV. Both ANCA and anti-GBM antibody may play a role in the development of end organ damage. To facilitate early and specific intervention, clinicians should be aware of the propensity of PTU to cause lupus-like syndromes with renal involvement. In patients with PTU-induced ANCA-associated glomerulonephritis, serum anti-GBM antibody test may be useful in the early diagnosis of double positive antibodies disease and plasmapheresis should be performed without delay. Keywords Anti-glomerular basement membrane antibody Antineutrophil cytoplasmic antibody Crescentic glomerulonephritis Propylthiouracil